Companies / EXENS
EPAExosens (EXENS) in our theses
Exosens appears in one of our theses. Below is why it entered the basket and how it has done since publication.
The German army is growing for the first time in 13 years, and the money is flowing not into tanks but into soldier equipment
Growing headcount in European armies is lifting spending on individual equipment faster than on platforms, and the bottleneck is image intensifiers.
Why this company: Sits right in the bottleneck: image intensifiers and sensors, produced in the West by a mere handful of plants. Constrained supply delivers a simultaneous rise in volume and margin, not just throughput.
Where these numbers come from
The reference price is recorded on the thesis publication date and never changed afterwards. The current price is refreshed several times a day. Returns are in the listing currency and exclude dividends, so for dividend payers the real total return was somewhat higher.
This is not a recommendation to buy or sell. A company enters a basket as a beneficiary of the mechanism described in the thesis, and the full argument is on each thesis page.
See all of our theses
Each with a publication date, a causal map and a score assigned before the market ruled.
Open in Invesaro →